Listed

Nephros Inc: Form 10-Q for the period ended Jun 30, 2016

Filed with the SEC on Aug 8, 2016 and accepted by EDGAR at Aug 8, 2016, 07:32 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-04-01 to 2016-06-30$509.0kus-gaap:SalesRevenueNet
Revenue6 months2016-01-01 to 2016-06-30$1.1mus-gaap:SalesRevenueNet
Cost of revenue3 months2016-04-01 to 2016-06-30$212.0kus-gaap:CostOfGoodsSold
Cost of revenue6 months2016-01-01 to 2016-06-30$507.0kus-gaap:CostOfGoodsSold
Gross profit3 months2016-04-01 to 2016-06-30$297.0kus-gaap:GrossProfit
Gross profit6 months2016-01-01 to 2016-06-30$592.0kus-gaap:GrossProfit
Selling, general and administrative3 months2016-04-01 to 2016-06-30$804.0kus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2016-01-01 to 2016-06-30$1.6mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2016-04-01 to 2016-06-30−$817.0kus-gaap:OperatingIncomeLoss
Operating income6 months2016-01-01 to 2016-06-30−$1.6mus-gaap:OperatingIncomeLoss
Interest expense3 months2016-04-01 to 2016-06-30$30.0kus-gaap:InterestExpense
Interest expense6 months2016-01-01 to 2016-06-30$44.0kus-gaap:InterestExpense
Net income3 months2016-04-01 to 2016-06-30−$835.0kus-gaap:NetIncomeLoss
Net income6 months2016-01-01 to 2016-06-30−$1.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-04-01 to 2016-06-30−$0.02us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2016-01-01 to 2016-06-30−$0.03us-gaap:EarningsPerShareBasicAndDiluted
Basic EPS3 months2016-04-01 to 2016-06-30−$0.02us-gaap:EarningsPerShareBasic
Basic EPS6 months2016-01-01 to 2016-06-30−$0.03us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2016-04-01 to 2016-06-3048,545,720 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2016-01-01 to 2016-06-3048,359,620 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2016-01-01 to 2016-06-30−$794.0kus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure6 months2016-01-01 to 2016-06-30$40.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2016-06-30$1.6mus-gaap:Cash
Current assetsAt period end2016-06-30$2.5mus-gaap:AssetsCurrent
Total assetsAt period end2016-06-30$4.0mus-gaap:Assets
Current liabilitiesAt period end2016-06-30$1.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-06-30$2.3mus-gaap:Liabilities
Shareholders' equityAt period end2016-06-30$1.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-16-012065. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.